Chief Scientific Adviser holds a deferred bonus of 43,111 shares worth £600,000

Conflict of interest row as it emerges Chief Scientific Officer Sir Patrick Vallance has £600,000 of shares in vaccine maker

By Daily Mail —— Bio and Archives September 24, 2020

Comments | Print This | Subscribe | Email Us

Sir Patrick Vallance has a £600,000 shareholding in a pharmaceuticals giant which is racing to develop a Covid vaccine for the Government, a report has revealed. The Chief Scientific Adviser holds the deferred bonus of 43,111 shares in GlaxoSmithKline (GSK) from his time as president of the multinational company.-- More...

Daily Mail -- Bio and Archives | Comments

The Daily Mail is a British daily middle-market tabloid newspaper owned by the Daily Mail and General Trust and published in London. It is the United Kingdom’s second-biggest-selling daily newspaper after The Sun.